申请人:E.R. Squibb & Sons, Inc.
公开号:EP0159156A1
公开(公告)日:1985-10-23
New compounds are disclosed having the formula
wherein R1, R2, R3, n and X are as defined hereinafter. These new compounds are useful as hypotensive agents due to their angiotensin converting enzyme inhibition activity and. depending upon the definition of X, may also be useful as analgesics due to their enkephalinase inhibition activity.
这些新化合物具有血管紧张素转换酶抑制活性,因此可用作降血压药;根据 X 的定义,它们还具有脑啡肽酶抑制活性,因此也可用作镇痛药。